Meet the top 11 gene-editing biotechs

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…


A scientist wearing a white coat and pouring liquid into a beaker at Intellia Therapeutics' lab in Cambridge, Massachusetts.
Therapeutics is developing Crispr-based gene-editing medicines that could potentially cure diseases. Intellia

11 biotechs leading the gene-editing revolution, aiming to cure diseases with single treatments

Find the whole list here>>


Castor CEO Derk Arts stands in front of a monitor with a slide presentation and teleconferencing participants as three people sitting on couches look on
CEO Derk Arts, center, goes through slides about the clinical trial company’s COVID-19 work. Castor

This entrepreneur thinks computer simulations could replace human drug-trial participants by 2035. See the pitch deck that helped his startup raise $US45 ($AU61) million.

Get the full presentation>>


Nurse flu vaccine

Groups representing millions of healthcare workers demand vaccine mandates for doctors, nurses, and others in medical fields: ‘The nation depends on it’

Check it out>>


More stories we’re reading:


Sponsored event invite: Join Dr. David Shulkin, ninth secretary, US Department of Veteran Affairs, for a conversation that convenes health tech innovators and regulatory bodies at this free virtual event, “Regulating Healthcare at the Speed of Life,” sponsored by Healthy.io, on July 29, 12pm ET. Register here.


– Lydia